The effect of octreotide, an analog of somatostatin, on bleomycin-induced interstitial pulmonary fibrosis in rats

Drug and Chemical Toxicology

Volumn 36, Issue 2, 2013, Pages 181-186

  Tug, Tuncer ^a,b   Kara, Haki ^b   Karaoglu, Aziz ^c   Karatas, Fikret ^c   Turgut, Nergiz Hacer ^b   Ayan, Erhan ^d   Boran, Cetin ^a   Tug, Esra ^a  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^b CUMHURIYET UNIVERSITY   (Turkey)

^c FIRAT UNIVERSITY   (Turkey)

^d MERSIN UNIVERSITY   (Turkey)

Author keywords

Bleomycin; Octreotide; Pulmonary fibrosis; Rats

Indexed keywords

BLEOMYCIN; HYDROXYPROLINE; OCTREOTIDE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FIBROSING ALVEOLITIS; HISTOPATHOLOGY; LUNG PARENCHYMA; MALE; NONHUMAN; RANDOMIZATION; RAT; STATISTICAL SIGNIFICANCE; WISTAR RAT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; GASTROINTESTINAL AGENTS; HYDROXYPROLINE; INJECTIONS, SPINAL; MALE; OCTREOTIDE; PULMONARY FIBROSIS; RATS; RATS, WISTAR;

RATTUS; RATTUS NORVEGICUS;

EID: 84871207724     PISSN: 01480545     EISSN: 15256014     Source Type: Journal    
DOI: 10.3109/01480545.2012.710618     Document Type: Article

References (31)

1. Arslan, S. O., Zerin, M., Vural, H., Coskun, A. (2002). The effect of melatonin on bleomycin-induced pulmonary fibrosis. J Pin Res 32:21-25.
2. Ashcroft, T., Simpson, J. M., Timbrell, V. (1988). Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 41:467-470.
3. Baldysiak-Figiel, A., Jong-Hesse, Y. D., Lang, G. K., Lang, G. E. (2005). Octreotide inhibits growth factorYinduced and basal proliferation of lens epithelial cells in vitro. J Cataract Refract Surg 31:1059-1064.
4. Bang, U. C., Semb, S., Nojgaard, C., Bendtsen, F. (2008). Pharmacological approach to acute pancreatitis. World J Gastroenterol 14:2968-2976.
5. Chaudhary, N. I., Roth, G. J., Hilberg, F., Muller-Quernheim, J., Prasse, A., Zissel, G., et al. (2007). Inhibition of PDGF, VEGF, and FGF signalling attenuates fibrosis. Eur Respir J 29:976-985.
6. Chiba, T., Yamada, T. (1994). Gut somatostatin. In: Walsh, J. H., Dockray, G. J. (Eds.), Gut peptides: biochemistry and physiology (pp. 123-142). New York: Raven.
7. Cook, D. N., Brass, D. M., Schwartz, D. A. (2002). A matrix for new ideas in pulmonary fibrosis. Am J Resp Cell Mol Biol 27:122-124.
8. Crestani, B., Chapron, J., Wallaert, B., Bergot, E., Delaval, P., Israel-Biet, D., et al. (2012). Octreotide treatment of idiopathic pulmonary fibrosis: A proof-of-concept study. Eur Respir J 39:772-775.
9. Crystal, R.G., Fulmer, J.D., Roberts, W.C., Moss, M.L., Line, B.R., Reynolds, H.Y. (1976). Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. Ann Intern Med 85:769-788.
10. Gross, T. J., Hunninghake, G. W. (2001). Idiopathic pulmonary fibrosis. N Engl J Med 345:517-525.
11. Gunal, A. I, Duman, S., Sen, S., Unsal, A., Terzioglu, E., Akcicek, F., et al. (2001). By reducing TGF beta 1, octreotide lessens the peritoneal derangements induced by a high glucose solution. J Nephrol 14:184-189.
12. Kara, H., Karatas, F., Tug, T., Canatan, H., Karaoglu, A. (2010). Protective effect of octreotide on intra-tracheal bleomycin-induced oxidative damage in rats. Exp Toxicol Pathol 62:235-241.
13. Leandros, E., Antonakis, P. T., Albanopoulos, K., Dervenis, C., Konstadoulakis, M. M. (2004). Somatostatin versus octreotide in the treatment of patients with gastrointestinal and pancreatic fistulas. Can J Gastroenterol 18:303-306.
14. Lebtahi, R., Moreau, S., Marchand-Adam, S., Debray, M. P., Brauner, M., Soler, P., et al. (2006). Increased uptake of 111In-octreotide in idiopathic pulmonary fibrosis. J Nucl Med 47:1281-1287.
15. Leong, W. L., Pasieka, J. L. (2002). Regression of metastatic carcinoid tumors with octreotide therapy: two case reports and a review of the literature. J Surg Oncol 79:180-187.
16. Mata, M., Ruíz, A., Cerdá, M., Martinez-Losa, M., Cortijo, J., Santangelo, F., et al. (2003). Oral N-acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats. Eur Respir 22:900-905.
17. Nakao, A., Fujii, M., Matsumura, R., Kumano, K., Saito, Y., Miyazono, K., et al. (1999). Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J Clin Invest 104:5-11.
18. Ozyurt, H., Sogut, S., Yildirim, Z., Kart, L., Iraz, M., Armutcu, F., et al. (2004). Inhibitory effect of caffeic acid phenethyl ester on bleomycine-induced lung fibrosis in rats. Clin Chim Acta 339:65-75.
19. Sener, G., Cetinel, S., Erkanli, G., Gedik, N., Yegen, B. C. (2005). Octreotide ameliorates sepsis-induced pelvic inflammation in female rats by a neutrophil-dependent mechanism. Peptides 26:493-499.
20. Sener, G., Topaloglu, N., Sehirli, A. O., Ercan, F., Gedik, N. (2007). Resveratrol alleviates bleomycin-induced lung injuryin rats. Pulm Pharmacol Ther 20:642-649.
21. Sleijfer, S. (2001). Bleomycin-induced pneumonitis. Chest 120:617-624.
22. Snider, G. L., Gelli, R. R., Goldstein, R. R., O'Brien, J. J., Lucei, E. C. (1978). Chronic interstitial pulmonary fibrosis produced in hamsters by endrotracheal belomycin. Am Rev Respir Dis 117:289-297.
23. Venkatesan, N., Punithavathi, V., Chandrakasan, G. (1997). Curcumin protects bleomycin-induced lung injury in rats. Life Sci 61:PL5lYPL58.
24. Wallace, J. L., Boichot, E., Sidoti, C., Brecx, A., Paubert-Brequet, M. (1993). Protective effects of somatostatin against gastric damage induced byhemorrhagic shock, stress, and PAF in therat. Regul Peptides 47:195-193.
25. Wang, J., Zheng, H., Hauer-Jensen, M. (2001). In?uence of short-term octreotide administration on chronic tissue injury, transforming growth factor beta (TGFbeta) overexpression, and collagen accumulation in irradiated rat intestine. J Pharmacol Exp Ther 297:35-42.
26. Willis, B. C., Liebler, J. M., Luby-Phelps, K., Nicholson, A. G., Crandall, E. D., du Bois, R. M., et al. (2005). Induction of epithelialmesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1:potential role in idiopathic pulmonary fibrosis. Am J Pathol 166:1321-1332.
27. Woessner, J. F. (1961). The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch Biochem Biophys 93:440-447.
28. Yen, H. C., Chang, H. M., Majima, H. J., Chen, F. Y., Li, S. H. (2005). Levels of reactive oxygen species and primary antioxidant enzymes in WI38 versus transformed WI38 cells following bleomcyin treatment. Free Radic Biol Med 38:950-959.
29. Yildirim, Z., Kotuk, M., Erdogan, H., Iraz, M., Yagmurca, M., Kuku, I., et al. (2006). Preventive effect of melatonin on bleomycin-induced lung fibrosis in rats. J Pineal Res 40:27-33.
30. Yildirim, Z., Kotuk, M., Iraz, M., Kuku, I., Ulu, R., Armutcu, F., et al. (2005). Attenuation of bleomycin-induced lung fibrosis by oral sulfhydryl containing antioxidants in rats: erdosteine and N-acetylcysteine. Pulm Pharmacol Ther 18:367-373.
31. Yildirim, Z., Turkoz, Y., Kotuk, M., Armutcu, F., Gurel, A., Iraz, M., et al. (2004). E?ects of aminoguanidine and antioxidant erdosteine on bleomycin-induced lung ?brosis in rats. Nitric Oxide 11:156-165.